HUSSMAN STRATEGIC ADVISORS, INC. - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 228 filers reported holding SAGE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 2.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
HUSSMAN STRATEGIC ADVISORS, INC. ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$255,192
-56.2%
12,4000.0%0.05%
-54.2%
Q2 2023$583,048
-46.6%
12,400
-52.3%
0.11%
-37.4%
Q1 2023$1,090,960
+10.0%
26,0000.0%0.17%
+5.6%
Q4 2022$991,640
-2.6%
26,0000.0%0.16%
-8.0%
Q3 2022$1,018,000
+21.2%
26,0000.0%0.18%
+21.4%
Q2 2022$840,000
-2.4%
26,0000.0%0.14%
-13.2%
Q1 2022$861,000
-22.2%
26,0000.0%0.17%
-31.3%
Q4 2021$1,106,000
-66.5%
26,000
-65.1%
0.24%
-66.6%
Q3 2021$3,297,000
-22.0%
74,4000.0%0.73%
-17.0%
Q2 2021$4,227,00074,4000.88%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Integral Health Asset Management, LLC 409,000$17,399,0004.82%
Palo Alto Investors LP 781,730$33,255,0002.12%
DAFNA Capital Management LLC 180,306$7,670,0001.93%
Boxer Capital, LLC 1,094,000$46,539,0001.81%
Deep Track Capital, LP 500,000$21,270,0001.50%
Bellevue Group AG 3,228,004$137,319,0001.42%
EcoR1 Capital, LLC 940,636$40,015,0001.28%
Deep Track Capital, LP 400,000$17,016,0001.20%
Artal Group S.A. 1,000,000$42,540,0001.15%
SECTOR GAMMA AS 98,904$4,207,0000.99%
View complete list of SAGE THERAPEUTICS INC shareholders